Hostname: page-component-848d4c4894-nmvwc Total loading time: 0 Render date: 2024-06-23T08:39:52.224Z Has data issue: false hasContentIssue false
  • English
  • Français

Gabapentin Can Improve Dystonia in Confirmed Wilson Disease

Published online by Cambridge University Press:  23 September 2014

Margherita Lerose ,
Roberto Di Fabio ,
Mariano Serrao ,
Georgios Loudianos ,
Francesco Pierelli  and
Carlo Casali
Margherita Lerose
Affiliation:
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
Roberto Di Fabio*
Affiliation:
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
Mariano Serrao
Affiliation:
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
Georgios Loudianos
Affiliation:
Department of Biomedical Sciences and Biotechnology, Pozzilli (IS), Italy
Francesco Pierelli
Affiliation:
USC, Cagliari, Italy, IRCCS Neuromed, Pozzilli (IS), Italy
Carlo Casali
Affiliation:
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy
*
Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Corso della Repubblica,79, 04100 — Latina, Italy. Email: rodifa@gmail.com.
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Brief Communications
Information
Canadian Journal of Neurological Sciences , Volume 41 , Issue 2 , March 2014 , pp. 284 - 285
Copyright
Copyright © The Canadian Journal of Neurological 2014

References

1.Lorincz, MT.Neurologic Wilson’s disease. Ann NY Acad Sci. 2010;1184:173–87.Google Scholar
2.Purchase, R.The treatment of Wilson’s disease, a rare genetic disorder of copper metabolism. Sci Prog. 2013;96(Pt 1):19–32.Google Scholar
3.Aggarwal, A, Aggarwal, N, Nagral, A, Jankharia, G, Bhatt, M.A novel Global Assessment Scale for Wilson’s Disease (GAS for WD). Mov Disord. 2009;24(4):509–18.Google Scholar
4.Burke, R, Fahn, S, Marsden, CD, Bressman, S, Moskowitz, C, Friedman, J.Validity and reliability of a rating scale for the primary torsion dystonias. Neurology. 1985;35(1):73–7.CrossRefGoogle ScholarPubMed
5.Paliwal, VK, Gupta, PK, Pradhan, S.Gabapentin as a rescue drug in D-penicillamine–induced status dystonicus in patients with Wilson disease. Neurol India. 2010;58(5):761–3.Google Scholar
6.Fink, K, Meder, W, Dooley, DJ, Göthert, M.Inibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol. 2000;130(4):900–6.Google Scholar
7.Linazasoro Cristóbal, G.Efficacy and tolerance of gabapentin in dystonia and hemifacial spasm: a pilot study. Rev Neurol. 2001;33(5):408–10.Google Scholar
8.Pina, MA, Modrego, PJ.Dystonia induced by gabapentin. Ann Pharmacother. 2005;39(2):380–2.CrossRefGoogle ScholarPubMed